GSA Capital Partners LLP Has $2.68 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

GSA Capital Partners LLP lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 28.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,582 shares of the healthcare conglomerate’s stock after selling 1,836 shares during the period. GSA Capital Partners LLP’s holdings in UnitedHealth Group were worth $2,679,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on UNH. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Argus raised their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Finally, Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Up 1.5 %

Shares of UNH opened at $625.25 on Tuesday. The firm’s 50-day moving average price is $581.93 and its 200-day moving average price is $545.85. The firm has a market capitalization of $575.41 billion, a price-to-earnings ratio of 40.73, a PEG ratio of 1.81 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.34%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.